Genomic and Molecular Diversity of Influenza Viruses Circulating in Abuja, Nigeria: A Scoping Review

Molecular characterization of influenza viruses is critical for understanding viral evolution, informing vaccine strain selection, and strengthening epidemic and pandemic preparedness). In Nigeria, influenza surveillance is conducted through national and global networks; however, molecular data specific to Abuja, the Federal Capital Territory, remain fragmented and under-synthesized. This scoping review aimed to map and summarize available evidence on the molecular characteristics of influenza viruses circulating in Abuja, Nigeria. A scoping review was conducted in accordance with the Arksey and O’Malley framework and the PRISMA-ScR guidelines. Peer-reviewed articles, national surveillance reports, and genomic databases published between January 2009 and January 2025 were searched across PubMed, Scopus, Google Scholar, African Journals Online, World Health Organization repositories, and the GISAID EpiFlu™ database. Studies reporting molecular or genetic analyses of influenza viruses from Abuja or national datasets that included Abuja were eligible for inclusion. Available evidence indicates the co-circulation of influenza A(H1N1)pdm09, influenza A(H3N2), and influenza B viruses in Abuja Molecular analyses demonstrate ongoing genetic drift in hemagglutinin and neuraminidase genes, with Abuja-derived viruses clustering phylogenetically with contemporaneous global strains, suggesting repeated viral introductions rather than sustained local evolution. Although current data indicate continued susceptibility to neuraminidase inhibitors, routine antiviral resistance monitoring and whole-genome sequencing specific to Abuja remain limited. In conclusion, influenza viruses circulating in Abuja exhibit genetic diversity consistent with global transmission dynamics. However, Abuja-specific molecular data are sparse, underscoring the need for expanded genomic surveillance and localized reporting to support evidence-based public health decision-making, vaccine policy, and pandemic preparedness in Nigeria.

Influenza virus; Molecular characterization; Genomic surveillance; Abuja

1. Agoti CN, Otieno JR, Gitahi CW, Kiyuka PK, Muthuri SG, Nokes DJ. Genomic epidemiology of influenza viruses in sub-Saharan Africa. Lancet Microbe. 2024;5(3):e210–e220. [Google Scholar] [Crossref]

2. Akinloye OM, Adekunle AI, Olawoye IB, Fasina FO, Adeniji JA. Genetic diversity and evolution of influenza A and B viruses in Nigeria, 2018–2023. Influenza Other Respir Viruses. 2024;18(2):e13245. [Google Scholar] [Crossref]

3. Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32. [Google Scholar] [Crossref]

4. Bedford T, Suchard MA, Lemey P, Dudas G, Gregory V, Hay AJ, et al. Integrating genomics and epidemiology to track influenza virus evolution. Nat Rev Microbiol. 2024;22:45–59. [Google Scholar] [Crossref]

5. Centers for Disease Control and Prevention. Influenza antiviral resistance: global update. Atlanta (GA): CDC; 2024. [Google Scholar] [Crossref]

6. GISAID Initiative. EpiFlu™ database: influenza virus sequences from Nigeria [Internet]. 2025 [cited 2025 Jan]. Available from: https://www.gisaid.org [Google Scholar] [Crossref]

7. Ihekweazu C, Happi C, Omoleke S, Salako BL. Strengthening pathogen genomics in Nigeria: progress and priorities. BMJ Glob Health. 2024;9(4):e013456. [Google Scholar] [Crossref]

8. Nigeria Centre for Disease Control and Prevention. National influenza sentinel surveillance report, Nigeria (2022–2024). Abuja: NCDC; 2024. [Google Scholar] [Crossref]

9. Nigeria Centre for Disease Control and Prevention. Integrated Disease Surveillance and Response (IDSR) annual report 2024. Abuja: NCDC; 2025. [Google Scholar] [Crossref]

10. Oladipo EK, Ajogbasile FV, Alonge OO, Oyedeji SI. Molecular surveillance of seasonal influenza viruses in West Africa reveals continuous viral introductions. Viruses. 2024;16(7):1021. [Google Scholar] [Crossref]

11. Otu A, Ebenso B, Eteng OE, Ameh S. Respiratory virus surveillance in urban West Africa: implications for pandemic preparedness. PLoS Glob Public Health. 2025;5(1):e0002874. [Google Scholar] [Crossref]

12. Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73. [Google Scholar] [Crossref]

13. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2024–2025 northern hemisphere influenza season. Wkly Epidemiol Rec. 2024;99(10):85–100. [Google Scholar] [Crossref]

14. World Health Organization. Global Influenza Surveillance and Response System (GISRS): annual report 2024. Geneva: WHO; 2025. [Google Scholar] [Crossref]

• Tribal Child Nutrition and Health in District of Sundargarh: A Public Health Review of ICDS Intervention
• Knowledge, Attitudes and Practices Towards Prostate Cancer Screening Amongst Men Aged 40-60 Years in The Buea Health District: A Cross-Sectional Study
• Compliance with JCI Protocols: A Focus on Employee Safety
• Influence and Involvement of Teachers in Menstrual Hygiene Management of Female Secondary School Students in Kogi State, Nigeria
• A Critical Evaluation of Ayushman Bharat Pradhan Mantri Jan Arogya Yojana in Bihar